|
Vol 46(2012) N 3 p. 362-374; T.A. Shelkovnikova1,3*, A.A. Kulikova3, P.O. Tsvetkov3, O. Peters2, S.O. Bachurin1, V.L. Buchman2, N.N. Ninkina1,2 Proteinopathies, Neurodegenerative Disorders with Protein Aggregation-Based Pathology 1Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, 142432 Russia2Cardiff University, Cardiff, CF10 3 US, UK 3Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia *sta.ipac@gmail.com Received - 2011-08-21; Accepted - 2011-10-14 A number of neurodegenerative disorders were recently coalesced into a group of proteinopathies based on the similarity of molecular mechanisms underlying their pathogenesis. A key step in the development of proteinopathies is a structural change that triggers aggregation of the proteins that are intrinsically prone to form aggregates owing to their physical and chemical properties. The review considers the recent progress in the field of proteinopathies with a special focus on the properties of aggregation-prone proteins, the main stages of the development of molecular pathology, and the role of cell clearance systems in the progression of neurodegeneration. Recent modifications made to the nomenclature of neurodegenerative diseases on the basis of the molecular mechanism of neurodegeneration are also addressed. neurodegenerative disorders, proteinopathies, amyloid, synuclein, prions |